# Study to Investigate Effects of CAL-101 in Subjects With Allergic Rhinitis Exposed to Allergen in an Environmental Chamber

> **NCT00836914** · PHASE1 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 41 (actual)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** CAL-101
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00836914
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2018-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00836914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00836914, "Study to Investigate Effects of CAL-101 in Subjects With Allergic Rhinitis Exposed to Allergen in an Environmental Chamber". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00836914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*